Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (U24 Clinical Trial Not Allowed)
ID: 355496Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355496

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-038.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for a funding opportunity titled "Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA)," aimed at establishing a Data Coordination Center (DCC) for the TranSINDA Consortium. The DCC will serve as the central hub for managing and sharing data from various TranSINDA research projects, promoting a modern data ecosystem that adheres to common data standards and facilitates large-scale data analysis and visualization. This initiative is crucial for enhancing understanding of socioenvironmental factors affecting neurocognitive development and addiction risk, thereby supporting the NIH's commitment to advancing health research through collaborative data efforts. Interested applicants, including higher education institutions and nonprofits, must submit their proposals by December 4, 2024, with a total funding allocation of $1 million available for this five-year project. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DA-25-038-Full-Announcement.html
    RFA-DA-25-038.html
    The Department of Health and Human Services' funding opportunity aims to establish a Data Coordination Center (DCC) for the Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) Consortium. This DCC will manage and share data from TranSINDA research projects at the National Institute on Drug Abuse (NIDA) and integrate various data sources under common standards to promote open science. The NOFO emphasizes the need for a multidisciplinary team to coordinate activities across key areas: Data Standards, Data Management, Statistical and Modeling Support, and Coordination, Dissemination, and Education. Applicants are encouraged to enhance diverse perspectives through a required Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity and innovation. The DCC will allocate $1M for this initiative, which will not involve clinical trials and has a maximum project period of five years. Eligible organizations, including higher education institutions and nonprofits, are invited to apply with a submission deadline of December 4, 2024. The program's focus on socioenvironmental influences on neurocognitive development aims to improve understanding of addiction risks and potential interventions, reinforcing the NIH's commitment to advancing health research through extensive data collaborations and support frameworks.
    Similar Opportunities
    Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk" (TranSINDA), aimed at advancing research on the impact of early-life socioenvironmental factors on neurocognitive development and addiction risk. This initiative seeks applications for team-science research projects that utilize longitudinal research designs in animal models to elucidate mechanisms linking early social environments to substance use disorders (SUD) and their comorbidities. A total of $4 million is anticipated for FY 2025, with funding available for up to seven projects over a maximum period of five years. Interested applicants must submit their proposals by November 8, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for a cooperative agreement to establish the Data Coordinating Center (DCC) for the Stillbirth Research Consortium, aimed at reducing stillbirth rates, particularly among marginalized populations. The DCC will be responsible for managing data collection, providing technical support, and enhancing coordination among various research projects focused on stillbirth prevention. This funding opportunity underscores the federal government's commitment to addressing perinatal mortality through innovative research strategies and interdisciplinary collaboration. Interested applicants should note that the application submission period begins on October 1, 2024, with approximately $2.25 million available for FY 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Data Coordinating Center (DCC) for multi-site investigator-initiated clinical trials under funding opportunity PAR-22-193. This initiative aims to support trials that evaluate efficacy, comparative effectiveness, and implementation strategies relevant to the mission of the National Heart, Lung, and Blood Institute (NHLBI), emphasizing collaboration with a Clinical Coordinating Center (CCC). The DCC will be responsible for comprehensive project coordination, data management, and biostatistical support, ensuring adherence to participant safety and diverse population recruitment. Interested applicants must submit both DCC and CCC applications concurrently by September 11, 2025, and can seek early consultation with NIH staff for guidance. For further details, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-22-193.html.
    Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Data Coordinating Center (Collaborative U24 Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for a phased multi-site clinical trial aimed at preventing cardiovascular disease (CVD) in young adults with high lifetime risk, specifically through the establishment of a Data Coordinating Center (DCC). The DCC will be responsible for overall project coordination, administration, data management, and biostatistical support for the trial, which will evaluate the efficacy of pharmacological interventions against a control group while focusing on health equity and community engagement. This initiative is critical for addressing the rising incidence of CVD among young adults by employing innovative trial designs and strategies to enhance diverse perspectives. Applications are due by October 28, 2024, with a total budget allocation starting at $972,356 for fiscal year 2025, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Translational Resource Centers to Build Bridges Between Substance Use Epidemiology/Etiology and Prevention Intervention Research (U24 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Translational Resource Centers aimed at bridging substance use epidemiology and prevention intervention research. This initiative seeks to form multidisciplinary research teams that will utilize epidemiological datasets to address substance use prevention questions and develop actionable intervention strategies. With a funding ceiling of $350,000 per project and a total allocation of $500,000, the grants are intended for projects lasting up to four years, although clinical trials are not permitted. Interested applicants must adhere to NIH guidelines and can reach out to NIH Grants Information at grantsinfo@nih.gov for inquiries. The application deadline is November 13, 2024.
    The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)" aimed at supporting the National Institute of Neurological Disorders and Stroke (NINDS) in maintaining and expanding its repository of human cell lines, specifically fibroblast and induced pluripotent stem cells (iPSCs). The initiative seeks to facilitate basic and translational research in neurological disorders by generating new cell lines, ensuring quality assessment standards, and distributing these resources to qualified researchers globally. With a total funding commitment of approximately $1.4 million for fiscal year 2025, eligible applicants include a wide range of organizations, such as educational institutions and non-profits, while proposals focused on non-human cell resources are excluded. Interested parties must submit their applications by October 17, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)" aimed at innovative analyses of existing datasets related to substance use behaviors and disorders. This initiative seeks to enhance understanding of the etiology and epidemiology of drug use, prevention strategies, and health service utilization by leveraging already available social science, neuroimaging, and administrative data, excluding primary data collection. The funding, with an anticipated commitment of $2 million for 3-5 awards, emphasizes compliance with ethical research practices and is open to a wide range of eligible applicants, including educational institutions and nonprofit organizations. Applications are due by November 15, 2024, and further details can be found at the provided link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) to enhance research on substance use, addiction, and HIV through collaborative efforts among investigators. This program aims to integrate diverse new and early career researchers, particularly from underrepresented backgrounds, to develop innovative approaches and interdisciplinary projects that transform the scientific research landscape. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and government entities, with a maximum project period of five years and a requirement to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested parties should note that the application deadline is November 17, 2025, and can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity to establish a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through a cooperative agreement. This initiative aims to provide technical development support for researchers working on new digital therapeutics for SUD, facilitating the transition from initial ideas to market-ready products. The program addresses the critical gap in early translational funding and aims to enhance the landscape of treatment options for substance use disorders by mentoring and educating researchers in formal product development. The maximum funding amount is $1.9 million per year, with applications accepted until November 13, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-056.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the establishment of a Data Management and Coordinating Center (DMCC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance the diagnosis, management, and treatment of rare diseases by facilitating collaborative, multi-site, patient-centric research through the RDCRN and supporting the activities of the Rare Diseases Clinical Research Consortia (RDCRC). The estimated total program funding for this grant is $1,000,000, with the FOA expected to be published in 2024 and awards anticipated in 2025. Interested applicants can reach out to Dr. Tiina K. Urv at urvtiin@mail.nih.gov or by phone at 301-827-2746 for further information.